These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 20442352)

  • 61. [Analysis on the efficacy in antiretroviral therapy and drug adverse reactions to HIV/AIDS between 2007 and 2012 in Yunnan province].
    Li JJ; Yang SM; Zhang M; Zhong M; Liu JF; Fan HL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Oct; 34(10):1045-6. PubMed ID: 24396907
    [No Abstract]   [Full Text] [Related]  

  • 62. [The 14th International Aids Conference: 'Knowledge, commitment and action'].
    Prins M; van Asten LC; Stolte IG; Dukers NH; Coutinho RA
    Ned Tijdschr Geneeskd; 2002 Oct; 146(40):1899-903. PubMed ID: 12395600
    [TBL] [Abstract][Full Text] [Related]  

  • 63. AIDS 2012: epidemiology, resources, and control.
    Flaskerud JH
    Issues Ment Health Nurs; 2013 Jun; 34(6):473-5. PubMed ID: 23805933
    [No Abstract]   [Full Text] [Related]  

  • 64. Experiencing uncertain HIV treatment delivery in a transitional setting: qualitative study.
    Bernays S; Rhodes T
    AIDS Care; 2009 Mar; 21(3):315-21. PubMed ID: 19280408
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Self-reported adherence to HAART in South-Eastern Nigeria is related to patients' use of pill box.
    Ukwe CV; Ekwunife OI; Udeogaranya OP; Iwuamadi UI
    SAHARA J; 2010 Jul; 7(1):10-5. PubMed ID: 21409290
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Lower perceived necessity of HAART predicts lower treatment adherence and worse virological response in the ATHENA cohort.
    de Boer-van der Kolk IM; Sprangers MA; van der Ende M; Schreij G; de Wolf F; Nieuwkerk PT
    J Acquir Immune Defic Syndr; 2008 Dec; 49(4):460-2. PubMed ID: 19011424
    [No Abstract]   [Full Text] [Related]  

  • 67. AIDS care: adhering to antiretroviral therapy.
    Brummet L
    Nurs BC; 2002 Oct; 34(4):24-5. PubMed ID: 12448910
    [No Abstract]   [Full Text] [Related]  

  • 68. Adherence to antiretrovirals in refugees and asylum seekers.
    Nwoguh F
    Nurs Times; 2005 Oct 25-31; 101(43):23-4. PubMed ID: 16276837
    [TBL] [Abstract][Full Text] [Related]  

  • 69. 3 million HIV/AIDS sufferers could receive anti-retroviral therapy by 2005.
    Indian J Med Sci; 2002 Sep; 56(9):456-7. PubMed ID: 12710346
    [No Abstract]   [Full Text] [Related]  

  • 70. HAART in India.
    John BV; Thomas S
    Lancet; 2004 Feb; 363(9407):493. PubMed ID: 14962542
    [No Abstract]   [Full Text] [Related]  

  • 71. Cohort profile: the German ClinSurv HIV project--a multicentre open clinical cohort study supplementing national HIV surveillance.
    Bätzing-Feigenbaum J; Kollan C; Kühne A; Matysiak-Klose D; Gunsenheimer-Bartmeyer B; Hamouda O;
    HIV Med; 2011 May; 12(5):269-78. PubMed ID: 20955355
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Epidemiology and therapy of pain and depression during HIV and AIDS].
    Husstedt IW; Reichelt D; Kästner F; Evers S; Hahn K
    Schmerz; 2009 Dec; 23(6):628-39. PubMed ID: 19787377
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Prevalence of HIV treatment in PHI].
    Wild F; Finkenstädt V
    Versicherungsmedizin; 2013 Dec; 65(4):202-4. PubMed ID: 24400400
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Related factors to non-adherence to antiretroviral therapy in HIV/AIDS patients.
    Arrieta-Martínez JA; Estrada-Acevedo JI; Gómez CA; Madrigal-Cadavid J; Serna JA; Giraldo PA; Quirós-Gómez Ó
    Farm Hosp; 2022 Nov; 46(6):319-326. PubMed ID: 36520570
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A randomized trial of the impact of a programmable medication reminder device on quality of life in patients with AIDS.
    Wu AW; Snyder CF; Huang IC; Skolasky R; McGruder HF; Celano SA; Selnes OA; Andrade AS
    AIDS Patient Care STDS; 2006 Nov; 20(11):773-81. PubMed ID: 17134351
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Full adherence to HAART: is it really necessary?
    Cainelli F; Vento S
    Arch Intern Med; 2002 Apr; 162(8):944-5; author reply 945. PubMed ID: 11966350
    [No Abstract]   [Full Text] [Related]  

  • 77. Features of AIDS and AIDS defining diseases during the highly active antiretroviral therapy (HAART) era, compared with the pre-HAART period: a case control study.
    Manfredi R; Chiodo F
    Sex Transm Infect; 2000 Apr; 76(2):145-6. PubMed ID: 10858726
    [No Abstract]   [Full Text] [Related]  

  • 78. [Monthly attendance at an immunodeficiency virus clinic acquired by resurtible prescription and adherence to antiretroviral treatment].
    Zonana-Nacach A; Torres-Salinas S; Franco-Esquivel SJ
    Salud Publica Mex; 2014; 56(5):423-4. PubMed ID: 25604282
    [No Abstract]   [Full Text] [Related]  

  • 79. San Francisco, California. A concerted effort to lighten the load.
    Cohen J
    Science; 2012 Jul; 337(6091):175-6. PubMed ID: 22798598
    [No Abstract]   [Full Text] [Related]  

  • 80. Adherence to HAART: an interview with William Holzemer. Interview by Tadd Tobias.
    Holzemer W
    BETA; 1999 Jan; 12(1):14-8. PubMed ID: 11367229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.